SERUM CD23 IS ASSOCIATED WITH NAIVE B CELL REPOPULATION AFTER RITUXIMAB IN ANCA ASSOCIATED VASCULITIS

被引：0
|
作者：
Harty, Len [1 ]
Smith, Rona [1 ]
Gopaluni, Seerapani [1 ]
Leandro, Maria [2 ]
Cambridge, Geraldine [2 ]
Jayne, David [1 ]
机构：
[1] Cambridge Univ Hosp Trust, Vasculitis, Cambridge, England
[2] UCL, Rayne Inst, London, England
来源：
RHEUMATOLOGY | 2017年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2_160
引用
收藏
页码：159 / 159
页数：1
相关论文
共 50 条
  • [41] Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial
    Zonozi, Reza
    Cortazar, Frank B.
    Jeyabalan, Anushya
    Sauvage, Gabriel
    Nithagon, Pravarut
    Huizenga, Noah R.
    Rosenthal, Jillian M.
    Sipilief, Alexander
    Cosgrove, Katherine
    Laliberte, Karen A.
    Rhee, Eugene P.
    Pendergraft III, William F.
    Niles, John L.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (03) : 351 - 359
  • [42] NO RECOVERY OF PERIPHERAL B-CELLS AFTER A SINGLE COURSE OF RITUXIMAB IN NEWLY DIAGNOSED AND TREATMENT-NAIVE PATIENTS WITH ANCA ASSOCIATED VASCULITIS (AAV)
    Gregorini, Gina
    Salviani, Chiara
    Jeannin, Guido
    Zubani, Roberto
    Cancarini, Giovanni
    RHEUMATOLOGY, 2017, 56
  • [43] Dysregulation of B cell function in ANCA-associated vasculitis
    Benassini, B.
    Staniek, J.
    Schmidt, F.
    Lorenzetti, R.
    Smulski, C.
    Schneider, P.
    Thiel, J.
    Venhoff, N.
    Rizzi, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 391 - 391
  • [44] B-cell treatment in ANCA-associated vasculitis
    Karras, Alexandre
    Lazareth, Helene
    Chauvett, Sophie
    RHEUMATOLOGY, 2020, 59 : 68 - 73
  • [45] ANCA Response upon Rituximab or Cyclophosphamide in ANCA-associated Vasculitis Patients
    van Dam, Laura
    Dirikgil, Ebru
    Bredewold, Edwin
    Ray, Argho
    Rabelink, Ton
    van Kooten, Cees
    Teng, Onno
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [46] Impact of rituximab trials on the treatment of ANCA-associated vasculitis
    Alberici, Federico
    Jayne, David R. W.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (06) : 1151 - 1159
  • [47] A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis
    Arnold, Jack
    Vital, Edward M.
    Dass, Shouvik
    Aslam, Aamir
    Rawstron, Andy C.
    Savic, Sinisa
    Emery, Paul
    Yusof, Md Yuzaiful Md
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [48] Rituximab for ANCA-associated vasculitis: The experience in the United States
    Clain, Jeremy M.
    Specks, Ulrich
    PRESSE MEDICALE, 2013, 42 (04): : 530 - 532
  • [49] Long-term rituximab for ANCA-associated vasculitis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (07): : E389 - E389
  • [50] Rituximab for ANCA-associated vasculitis in the setting of severe infection
    Gregersen, J. W.
    Chaudhry, A.
    Jayne, D. R. W.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (03) : 207 - 210
12345